These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33474955)

  • 1. A 12-hour rapid titration method for cancer pain: a randomized, controlled, open-label study.
    Liang J; Chen L; Yang S; Zhang H; Li L; Chen Z; Zhang S; Xian H; Tang Y; Deng Y; Feng W
    Ann Palliat Med; 2021 Jan; 10(1):88-96. PubMed ID: 33474955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of sustained-release oxycodone compared with immediate-release morphine for pain titration in cancer patients: A multicenter, open-label, randomized controlled trial (SOCIAL).
    Pan H; Shen P; Shu Q; Lu L; Qian S; Zhou Y; Han F; Guo Q; Yang Z; Pan J; Xu Q; Zhang P; Wang K
    Medicine (Baltimore); 2019 Jun; 98(24):e15505. PubMed ID: 31192908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.
    Nakajima N
    Jpn J Clin Oncol; 2019 Dec; 49(11):1061-1064. PubMed ID: 31612910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid titration with sustained-release oxycodone and immediate-release morphine for moderate/severe cancer pain: a pilot assessment of the CoDem protocol.
    Samolsky Dekel BG; Tomasi M; Vasarri A; Gori A; Adversi M; Castagnoli A; Di Nino G; Melotti RM
    J Opioid Manag; 2014; 10(1):29-38. PubMed ID: 24604567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, open-label study of once-a-day AVINZA (morphine sulfate extended-release capsules) versus twice-a-day OxyContin (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: the extension phase of the ACTION trial.
    Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
    J Opioid Manag; 2006; 2(6):325-8, 331-3. PubMed ID: 17326594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxycodone versus morphine for cancer pain titration: A systematic review and pharmacoeconomic evaluation.
    Zhou J; Wang Y; Jiang G
    PLoS One; 2020; 15(4):e0231763. PubMed ID: 32302346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Patient-Controlled Analgesia Versus Oral Opioid to Maintain Analgesia for Severe Cancer Pain: A Randomized Phase II Trial.
    Lin R; Zhu J; Luo Y; Lv X; Lu M; Chen H; Zou H; Zhang Z; Lin S; Wu M; Li X; Zhou M; Zhao S; Su L; Liu J; Huang C
    J Natl Compr Canc Netw; 2022 Sep; 20(9):1013-1021.e3. PubMed ID: 36075387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous Oxycodone versus Intravenous Morphine in Cancer Pain: A Randomized, Open-Label, Parallel-Group, Active-Control Study.
    Lee KH; Kang JH; Oh HS; Choi MK; Shim BY; Eum YJ; Park HJ; Kang JH
    Pain Res Manag; 2017; 2017():9741729. PubMed ID: 29670416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphine Versus Oxycodone for Cancer Pain Using a Catechol-O-methyltransferase Genotype Biomarker: A Multicenter, Randomized, Open-Label, Phase III Clinical Trial (RELIEF Study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Sakai K; Yoshida T; Nakura M; Sakamoto R; Makimura C; Ohtake Y; Tanaka K; Hayashi H; Takeda M; Okuno T; Takegawa N; Haratani K; Koyama A; Nishio K; Nakagawa K
    Oncologist; 2023 Mar; 28(3):278-e166. PubMed ID: 36426809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003870. PubMed ID: 25723351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid titration with oral sustained-release morphine plus subcutaneous morphine in a multi-center, randomized control study of cancer patients with moderate to severe cancer pain.
    Sun Y; Wei H; Yu M; Zheng R; Li J; Fu Y; Zheng Y; Zhang X; Shou F; Zhou J; Yao W; Chen P; Liu D; Jia Y; Fu Y; Wang Y; Zhu J
    Jpn J Clin Oncol; 2022 Nov; 52(11):1303-1310. PubMed ID: 35946332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ACTION study: a randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin) for the treatment of chronic, moderate to severe low back pain.
    Rauck RL; Bookbinder SA; Bunker TR; Alftine CD; Ghalie R; Negro-Vilar A; de Jong E; Gershon S
    J Opioid Manag; 2006; 2(3):155-66. PubMed ID: 17319449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo) in the treatment of postoperative pain.
    Richards P; Riff D; Kelen R; Stern W;
    J Opioid Manag; 2011; 7(3):217-28. PubMed ID: 21823552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical study on fluvoxamine combined with oxycodone prolonged-release tablets in treating patients with moderate to severe cancer pain.
    Xiao Y; Liu J; Huang XE; Ca LH; Ma YM; Wei W; Zhang RX; Huang XH; Chang J; Wu YJ
    Asian Pac J Cancer Prev; 2014; 15(23):10445-9. PubMed ID: 25556490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.
    Joppich R; Richards P; Kelen R; Stern W; Zarghooni K; Otto C; Böhmer A; Petzke F; Treptau T; Lefering R; Bäthis H; Neugebauer E
    Clin Ther; 2012 Aug; 34(8):1751-60. PubMed ID: 22795613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.
    Zecca E; Brunelli C; Bracchi P; Biancofiore G; De Sangro C; Bortolussi R; Montanari L; Maltoni M; Moro C; Colonna U; Finco G; Roy MT; Ferrari V; Alabiso O; Rosti G; Kaasa S; Caraceni A
    J Pain Symptom Manage; 2016 Dec; 52(6):783-794.e6. PubMed ID: 27742577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
    Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
    J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled-release oxycodone and morphine in cancer related pain.
    Heiskanen T; Kalso E
    Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical observation of filiform fire needling on moderate and severe pain in advanced cancer].
    Gao X; Zhang SN
    Zhongguo Zhen Jiu; 2020 Jun; 40(6):601-4. PubMed ID: 32538009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.